hotspot -WSS

hotspot

author：hotspot 2025-09-29 21:27:09 - browse：5575

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Telehealth options flood the market as retailers push virtual care

focus

WSS

Senate panel to vote on hospitals, PBMs, prisoner care

It's time to retire 'poor historian' from clinicians' vocabularies

Physician subsidies by hospitals soar in wake of No Surprises Act

Why Sanofi got shellacked over its spinoff

Cytokinetics CEO stresses company can launch heart drug on its own

The pink breast cancer awareness ribbon needs a redesign

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Emergency medicine has repudiated 'excited delirium.' Now what?

Psychedelics group wrestles with new pharma identity

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Medical leaders decry Supreme Court decision on affirmative action

Senate panel to vote on hospitals, PBMs, prisoner care

Apple is now the first public company to be valued at $3 trillion

Diversifying clinical trials isn't enough to close racial gaps: study

Alkermes shareholders re

The pink breast cancer awareness ribbon needs a redesign

hotspot

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

With measles on the rise, a personal story of a devastating disease

Why Sanofi got shellacked over its spinoff

Cytokinetics CEO stresses company can launch heart drug on its own

Medtronic CEO on promising devices for diabetes, hypertension

Helping hospitals and community health centers plan for resilience

hotspot

focus

focus

focus